LLY ELI LILLY & Co

Price (delayed)

$206.14

Market cap

$197.19B

P/E Ratio

33.52

Dividend/share

$2.96

EPS

$6.15

Enterprise value

$210.52B

Sector: Healthcare
Industry: Drug Manufacturers - General

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded ...

Highlights

The equity has increased by 43% year-on-year and by 18% since the previous quarter
The quick ratio has increased by 20% year-on-year and by 16% since the previous quarter
The P/E is 52% above the last 4 quarters average of 22.0 but 21% below the 5-year quarterly average of 42.3
The net income has contracted by 30% YoY
The EPS has decreased by 25% YoY

Key stats

What are the main financial stats of LLY
Market
Shares outstanding
956.58M
Market cap
$197.19B
Enterprise value
$210.52B
Valuations
Price to earnings (P/E)
33.52
Price to book (P/B)
40.85
Price to sales (P/S)
8.06
EV/EBIT
32.77
EV/EBITDA
27.27
EV/Sales
9.07
Earnings
Revenue
$23.21B
EBIT
$6.42B
EBITDA
$7.72B
Free cash flow
$5.39B
Per share
EPS
$6.15
Free cash flow per share
$5.94
Book value per share
$5.05
Revenue per share
$25.59
TBVPS
$35.97
Balance sheet
Total assets
$43.95B
Total liabilities
$38.95B
Debt
$16.92B
Equity
$4.83B
Working capital
$4.26B
Liquidity
Debt to equity
3.51
Current ratio
1.36
Quick ratio
0.79
Net debt/EBITDA
1.73
Margins
EBITDA margin
33.3%
Gross margin
78.3%
Net margin
24%
Operating margin
27.7%
Efficiency
Return on assets
13.4%
Return on equity
152.6%
Return on invested capital
19.9%
Return on capital employed
20.1%
Return on sales
27.7%
Dividend
Dividend yield
1.44%
DPS
$2.96
Payout ratio
48.1%

LLY stock price

How has the ELI LILLY stock price performed over time
Intraday
1.87%
1 week
8.06%
1 month
23.64%
1 year
45.62%
YTD
22.09%
QTD
22.09%

Financial performance

How have ELI LILLY's revenue and profit performed over time
Revenue
$23.21B
Gross profit
$18.17B
Operating income
$6.42B
Net income
$5.57B
Gross margin
78.3%
Net margin
24%
LLY's operating income is up by 42% year-on-year
ELI LILLY's net margin has decreased by 34% YoY and by 2% from the previous quarter
ELI LILLY's operating margin has increased by 33% YoY
The net income has contracted by 30% YoY

Growth

What is ELI LILLY's growth rate over time

Valuation

What is ELI LILLY stock price valuation
P/E
33.52
P/B
40.85
P/S
8.06
EV/EBIT
32.77
EV/EBITDA
27.27
EV/Sales
9.07
The P/E is 52% above the last 4 quarters average of 22.0 but 21% below the 5-year quarterly average of 42.3
The EPS has decreased by 25% YoY
LLY's P/B is 111% above its 5-year quarterly average of 19.4 and 2.6% above its last 4 quarters average of 39.8
The equity has increased by 43% year-on-year and by 18% since the previous quarter
The stock's price to sales (P/S) is 68% more than its 5-year quarterly average of 4.8 and 39% more than its last 4 quarters average of 5.8
ELI LILLY's revenue has increased by 6% YoY

Efficiency

How efficient is ELI LILLY business performance
The ROA has contracted by 33% YoY and by 4.3% from the previous quarter
The ROS has decreased by 26% YoY
The ROIC has contracted by 25% YoY
The company's return on equity fell by 11% YoY and by 11% QoQ

Dividends

What is LLY's dividend history
DPS
$2.96
Dividend yield
1.44%
Payout ratio
48.1%
Recent dividends

Financial health

How did ELI LILLY financials performed over time
LLY's total assets is 13% greater than its total liabilities
The quick ratio has increased by 20% year-on-year and by 16% since the previous quarter
ELI LILLY's current ratio has increased by 16% YoY and by 11% from the previous quarter
The equity has increased by 43% year-on-year and by 18% since the previous quarter
The company's debt to equity fell by 24% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.